Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

Find out more

Home › Resources › Posters › High content imaging (HCI) assays enable the study of the fibrotic processes: fibroblast – to – myofibroblast transition (FMT) and epithelial – to – mesenchymal transition (EMT)

High content imaging (HCI) assays enable the study of the fibrotic processes: fibroblast – to – myofibroblast transition (FMT) and epithelial – to – mesenchymal transition (EMT)

Discover about how excessive and abnormal deposition of extracellular matrix (ECM) is a characteristic feature of fibrotic lung disease, such as idiopathic pulmonary fibrosis (IPF).
Learn about how repetitive injury to lower airway epithelial cells drives epithelial-to-mesenchymal transition (EMT).
In this study, we model FMT and EMT process in-vitro using high content imaging (HCI) enables compound screening to assist anti-fibrotic drug discovery.

Published

17th June, 2024

Published by

Fiona Leslie, Oliver Birch, Chloe Whiting, Megan Webster

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Please click the button below to download this resource.

Download Now

Book a Call